![]() CaaMTech CaaMTech is a drug discovery company that creates and optimizes psychedelic drugs to treat mental health conditions. | ![]() ACADIA Pharmaceuticals ACADIA Pharmaceuticals (formerly Receptor Technologies) is a biopharmaceutical company developing medicines that address medical needs in related central nervous system (CNS) disorders. | ![]() Supernus Pharmaceuticals Supernus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system disorders. | |
Founding Date | Founding Date 2019 | Founding Date 1993 | Founding Date 2005 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Issaquah, US HQ | Locations San Diego, US HQ Princeton, US | Locations Rockville, US HQ |
Employees | Employees 9 | Employees 513 | Employees 6527% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 2.4 b | Valuation ($) 1.9 b |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $1.1b (FY, 2025) | Revenue (est.) $719m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $89m (FY, 2025) | Cost of goods $74.6m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $982.5m (FY, 2025) | Gross profit $644.4m (FY, 2025) |
Net income | Net income N/A | Net income $391m (FY, 2025) | Net income ($38.6m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 22m | Total funding raised $ 770.8m | Total funding raised $ 69.5m |

ACADIA Pharmaceuticals (formerly Receptor Technologies) is a biopharmaceutical company developing medicines that address medical needs in related central nervous system (CNS) disorders.
View company
Supernus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system disorders.
View company